Bristol's $14 Billion Neuroscience Drug Bet Is an Early Letdown

Original Pub: Bloomberg
Publish Date: April 28, 2026
Author: Gerry Smith (w/ quote by Dr. Jeffrey A. Lieberman)

Analysts cut Cobenfy expectations as patients struggle to get the new drug.

Click to read published article (Bloomberg.com)
Photo Source / Credit: Patient holds a bottle of her current medication, Risperidone. (Photographer: Sophie Park / Bloomberg)